Gluten-Free Diet is Not Enough – Ongoing Intestinal Damage in Most Diagnosed Patients
Many people with celiac disease have significant disease-associated symptoms and intestinal damage despite trying to adhere to a strict gluten-free diet.
x
Opt-in to stay up-to-date on the latest news.
Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease. To view all information related to drug development and research, please visit our main celiac disease research page. Learn about the Beyond Celiac Science Department here.
Many people with celiac disease have significant disease-associated symptoms and intestinal damage despite trying to adhere to a strict gluten-free diet.
Looking for clues to celiac disease in infant study
Researchers have discovered that a human protein called elafin may be helpful in protecting against the inflammatory reaction seen in people with celiac disease.
Alba Therapeutics Corporation provides an update on their investigational medication, larazotide acetate.
A recent study published in Alimentary Pharmacology and Therapeutics demonstrated that a new, non-invasive test for celiac disease may be possible in the future.
Alvine Pharmaceuticals, Inc. provides an update on a clinical trial investigating a potential medication for celiac disease.
"We are all on a learning curve," says UK expert.
Updated information! A 9-year-old’s orthodontic retainer was found to be the cause of ongoing celiac disease symptoms, despite a strict elimination of gluten from her diet.
The NFCA team highlights key details discussed at the most comprehensive celiac disease meeting in the world.
The National Foundation for Celiac Awareness shares the results from a recent survey conducted by Dr. Dan Leffler, Director of Clinical Research at BIDMC and NFCA Scientific/Medical Advisory Council Member.
People with celiac disease are encouraged to share their opinion with researchers.This survey is now closed.
Researchers suggest new method for testing people for the autoimmune disease.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) seeking research study participants.
Fusion Antibodies Ltd have announced a collaboration with Swiss biotech company Calypso Biotech for development of their CALY-002 Antibody.
Benjamin Lebwohl, MD, MS responds to questions about his recent study on the celiac disease and lymphoma association.
Study seeks to learn more about the relationship between the autoimmune diseases and the underlying cause of type 1 diabetes.
Benjamin Lebwohl, MD, MS discusses research study results on the increased risk of lymphoma in people with celiac disease.
Researchers work to determine the sensitivity and reliability of the R5 competitive ELISA gluten test.
FDA approves change to drug label after reports of gastrointestinal problems and weight loss.
Researchers identify antibody response to gluten in children with autism, but say more research is needed to understand the response.
A new study reveals ongoing work to improve taste and choice among gluten-free products.
Joseph Murray, MD of the Mayo Clinic explains the potential pharmaceutical treatments for celiac disease.
Those struggling to maintain a gluten-free diet achieve better adherence through the promising resource, study suggests.
AbbVie secures exclusive option to acquire global rights to ALV003, which has the potential to be the first therapy to treat celiac disease.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to